Resilient and environmentally sustainable engineered crops to address climate change
Crop4Clima aims to develop canola and rapeseed lines that enhance CO2 assimilation and resilience, improving productivity and sustainability to meet future agricultural demands amid climate change.
Projectdetails
Introduction
Current global warming, caused by anthropogenic emissions of greenhouse gases (in particular CO2), is expected to rise from 2.5°C to 4°C by the end of the century. Consequently, agriculture is faced with the urging needs of increasing CO2 sequestration, coping with adverse weather and disastrous events (i.e., droughts, heat waves, fire, and flooding), and feeding an ever-growing world population projected at 9.7 billion in 2050.
Challenges in Agriculture
Future crops must serve as more efficient carbon sinks to mitigate climate change, plus have higher resilience and productivity to feed the global population.
- Increasing CO2 Sequestration
- Coping with Adverse Weather
- Feeding a Growing Population
Project Overview
Crop4Clima will develop first-of-a-kind canola and rapeseed lines able to assimilate 60% more CO2 through photorespiration, requiring 20% less water, improving biomass per hectare, and still maintaining high oil content values as required for canola-derived products. No commercial crops of that kind exist.
Innovative Approach
To reach such a product, we will improve and bring to commercial use a disruptive synthetic metabolic pathway, the TaCo pathway, which turns photorespiration into a CO2-fixing instead of a CO2-releasing process. This leads to increased net carbon uptake under agronomical standard and drought field conditions.
Importance of Canola and Rapeseed
Canola and rapeseed are major crops in the EU and worldwide. Notably, our technology has commercial prospects to be introduced in other C3 crops such as soybean, cotton, rice, and more, based on photosynthetic and genomic similarity.
Future Prospects
The success of the technology implementation in rapeseed will allow us to establish a start-up seed company aiming to produce and sell high oil seeds with a low carbon footprint.
Business Development
In addition, within the framework of the program, we will develop an innovative business plan taking into consideration how the food value chain is evolving to cope with food supply and climate change. This includes signing a pre-commercial agreement with our industrial partners for the development of our engineered crops up to TRL9 and building trust in the proposed solution.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.475.562 |
Totale projectbegroting | € 2.475.562 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 31-12-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- EVOGENE LTDpenvoerder
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
- IN SRL IMPRESA SOCIALE
- AGROBIOINSTITUTE
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
PLant AdaptioN to Elevated Temperatures: mitigating crop losses caused by climate changePLANeT aims to develop cost-effective lead compounds to enhance crop yield under elevated temperatures, leveraging Brassinosteroid receptor research for agricultural innovation. | ERC POC | € 150.000 | 2023 | Details |
Next-generation multi-targeted CRISPR genetic toolbox uncovers hidden breeding traitsMulti-Crop technology utilizes genome-scale multi-targeted CRISPR libraries to uncover hidden genetic traits in crops, revolutionizing plant breeding for enhanced resilience and productivity. | ERC POC | € 150.000 | 2023 | Details |
In planta jet injection: Efficient genetic engineering of resilient cropsThe project aims to develop affordable, high-throughput devices for efficient genome editing in crops to enhance yield and climate resilience, addressing global food security challenges by 2100. | ERC POC | € 150.000 | 2023 | Details |
Resilient Oats: Improving Drought Stress Resistance in a Changing ClimateRESIST aims to enhance drought resistance in oats through advanced genomics and breeding techniques, ensuring sustainable yields of this nutritious crop amid climate challenges. | ERC STG | € 1.499.961 | 2024 | Details |
PLant AdaptioN to Elevated Temperatures: mitigating crop losses caused by climate change
PLANeT aims to develop cost-effective lead compounds to enhance crop yield under elevated temperatures, leveraging Brassinosteroid receptor research for agricultural innovation.
Next-generation multi-targeted CRISPR genetic toolbox uncovers hidden breeding traits
Multi-Crop technology utilizes genome-scale multi-targeted CRISPR libraries to uncover hidden genetic traits in crops, revolutionizing plant breeding for enhanced resilience and productivity.
In planta jet injection: Efficient genetic engineering of resilient crops
The project aims to develop affordable, high-throughput devices for efficient genome editing in crops to enhance yield and climate resilience, addressing global food security challenges by 2100.
Resilient Oats: Improving Drought Stress Resistance in a Changing Climate
RESIST aims to enhance drought resistance in oats through advanced genomics and breeding techniques, ensuring sustainable yields of this nutritious crop amid climate challenges.